PB2034: CAMMA 1: A MULTICENTER PHASE IB TRIAL EVALUATING THE SAFETY, PHARMACOKINETICS AND ACTIVITY OF CEVOSTAMAB-CONTAINING REGIMENS IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPL...

por Vij, R., Schade, H., Trudel, S., Chang, A. C., Huang, J., Samineni, D., Sumiyoshi, T., Tsai, J., Wong, T., Harrison, S. J.
Publicado 2022

PB2035: CAMMA 3: A MULTICENTER PHASE IB TRIAL EVALUATING THE SAFETY, PHARMACOKINETICS, AND ACTIVITY OF SUBCUTANEOUS CEVOSTAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY M...

por Delimpasi, S., Quach, H., Cavo, M., Ho, P. J., Lee, C. H.-S., Santoro, A., Schots, R., Vlummens, P., Yoon, D. H., Yoon, S.-S., Santos, C. D., Samineni, D., Huang, J., Wehrman, K., Patil, U., Sheikh, S., Dimopoulos, M. A.
Publicado 2022